Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sneeze, Wheeze & Itch Associates (SWIA), also known as Midwest Allergy Sinus Respiratory, is a specialized medical practice and clinical research center based in Central Illinois. The organization provides comprehensive care for allergy, asthma, immunology, and respiratory conditions for both pediatric and adult patients. In addition to clinical care, SWIA operates a robust clinical research division that conducts Phase I-IV clinical trials for major pharmaceutical companies, focusing on areas such as atopic dermatitis, asthma, food allergies, and chronic spontaneous urticaria. The center is recognized for its expertise in complex immunologic diseases and its participation in pivotal trials for innovative therapies like lebrikizumab and ruxolitinib.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sneeze, Wheeze & Itch Associates.